Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hernando Patino

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMC Pharmacology & Toxicology|March 29, 2017
Pharmacokinetics of surotomycin from phase 1 single and multiple ascending dose studies in healthy volunteersGurudatt Chandorkar, Qiao Zhan, Julie Donovan, et al.
Pharmacotherapy|November 29, 2007
Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host diseaseGopal Krishna, Monika Martinho, Pranatharthi Chandrasekar, et al.
Thrombosis Research|December 17, 2025
The in vitro anticoagulant effect of milvexian in healthy neonates and childrenNatasha Letunica, Vasiliki Karlaftis, Paul Monagle, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|March 24, 2006
Posaconazole treatment of refractory eumycetoma and chromoblastomycosisRicardo Negroni, Angela Tobón, Beatriz Bustamante, et al.
The Journal of Antimicrobial Chemotherapy|July 20, 2016
Surotomycin versus vancomycin for Clostridium difficile infection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trialChristine H Lee, Hernando Patino, Chris Stevens, et al.
Transplantation|September 25, 2008
Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplantBarbara D Alexander, John R Perfect, Jennifer S Daly, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2009
Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida speciesPaul A Mann, Paul M McNicholas, Andrew S Chau, et al.
Antimicrobial Agents and Chemotherapy|April 16, 2014
Phase 1B study of the pharmacokinetics and safety of posaconazole intravenous solution in patients at risk for invasive fungal diseaseJohan Maertens, Oliver A Cornely, Andrew J Ullmann, et al.
The Pediatric Infectious Disease Journal|February 7, 2018
Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal BacteremiaAntonio C Arrieta, John S Bradley, Myra W Popejoy, et al.
Pediatrics|February 17, 2017
Daptomycin for Complicated Skin Infections: A Randomized TrialJohn Bradley, Chad Glasser, Hernando Patino, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMC Pharmacology & Toxicology|March 29, 2017
Pharmacokinetics of surotomycin from phase 1 single and multiple ascending dose studies in healthy volunteersGurudatt Chandorkar, Qiao Zhan, Julie Donovan, et al.
Pharmacotherapy|November 29, 2007
Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host diseaseGopal Krishna, Monika Martinho, Pranatharthi Chandrasekar, et al.
Thrombosis Research|December 17, 2025
The in vitro anticoagulant effect of milvexian in healthy neonates and childrenNatasha Letunica, Vasiliki Karlaftis, Paul Monagle, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|March 24, 2006
Posaconazole treatment of refractory eumycetoma and chromoblastomycosisRicardo Negroni, Angela Tobón, Beatriz Bustamante, et al.
The Journal of Antimicrobial Chemotherapy|July 20, 2016
Surotomycin versus vancomycin for Clostridium difficile infection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trialChristine H Lee, Hernando Patino, Chris Stevens, et al.
Transplantation|September 25, 2008
Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplantBarbara D Alexander, John R Perfect, Jennifer S Daly, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2009
Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida speciesPaul A Mann, Paul M McNicholas, Andrew S Chau, et al.
Antimicrobial Agents and Chemotherapy|April 16, 2014
Phase 1B study of the pharmacokinetics and safety of posaconazole intravenous solution in patients at risk for invasive fungal diseaseJohan Maertens, Oliver A Cornely, Andrew J Ullmann, et al.
The Pediatric Infectious Disease Journal|February 7, 2018
Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal BacteremiaAntonio C Arrieta, John S Bradley, Myra W Popejoy, et al.
Pediatrics|February 17, 2017
Daptomycin for Complicated Skin Infections: A Randomized TrialJohn Bradley, Chad Glasser, Hernando Patino, et al.
Pageof 2